Scientists successfully test new skin cancer drug
Sydney: Scientists have successfully tested a new class of drugs in humans that targets a rogue protein responsible for the proliferation of skin cancer, says a study.
The research involves the drug Dz13, a targeted molecular therapy, which was developed at the University of New South Wales (UNSW) and has now been found to be safe in a clinical trial of patients with the common skin cancer, basal-cell carcinoma.
"This is the first report of a drug of this type to be used in humans," says UNSW Medicine`s Professor Levon Khachigian, who has been developing the DNAzyme technology for 10 years.
"It`s a smart drug, which targets a bad protein that controls tumour growth and spread," says Professor Khachigian, the Director of the UNSW Centre for Vascular Research.
The collaborative trial was conducted by researchers from UNSW, the University of Sydney and Royal Prince Alfred Hospital, reports Science Daily. The findings have been published in the journal The Lancet.
More from India
More from World
More from Sports
More from Entertaiment
- Watch - Huge fire breaks out at petrol pump in Kota, Rajasthan
- NSG now 'nine times' stronger; receives technological strength from 12 countries!
- Bihar: Congress leader Brajesh Pandey accused of running sex racket
- BJP MP Yogi Adityanath compares Akhilesh Yadav with 'Aurangzeb' and 'Kans'
- Acrimonious remarks of political leaders during UP elections
- Reliance Jio's tariff plan from April 1; voice calls, roaming to be free: Mukesh Ambani
- 7th Pay Commission: Allowances committee raises HRA to 30%?
- Virat Kohli thanks sprint legend Usain Bolt for congratulating him on 'record' Puma deal
- BMC exit poll: BJP predicted to score big in neck-and-neck battle with Shiv Sena
- IPL 2017 Auction: Reaction-filled Twitter erupts with emotions!